On the other hand, LOXL2 was reported to activate the process of angiogenesis through upregulating the HIF-1α/VEGF pathway [8] and promote HCC metastasis to distant organ via an AKT/fibronectin-dependent pathway [9]. This evidence concerns the gene LOXL2 and hepatocellular carcinoma.